中文English
ISSN 1001-5256 (Print)
ISSN 2097-3497 (Online)
CN 22-1108/R

留言板

尊敬的读者、作者、审稿人, 关于本刊的投稿、审稿、编辑和出版的任何问题, 您可以本页添加留言。我们将尽快给您答复。谢谢您的支持!

姓名
邮箱
手机号码
标题
留言内容
验证码

基质金属蛋白酶及其抑制剂与肝癌关系的研究进展

赵玮 宣世英 孙樱

引用本文:
Citation:

基质金属蛋白酶及其抑制剂与肝癌关系的研究进展

详细信息
  • 中图分类号: R735.7

  • [1]Lynch C C, Matrisian LM.Matrix metalloproteinases in tumor-hostcell communication[J].Differentiation, 2002, 70 (9-10) ∶561-573.
    [2]Alper O, Bergmann-Leitner E S, Bennett T A, et al.Epidermalgrowth factor receptor signaling and the invasive phenotype of ovariancarcinoma cells[J].J Natl Cancer Inst, 2001, 93 (18) ∶1375-1384.
    [3]Cox G, O'byrne K J.Matrix metalloproteinases and cencer[J].Anti-cancer Res, 2001, 21 (6B) ∶4207-4219.
    [4]谢玉梅, 聂青和, 周永兴, 等.TIMP-1和TIMP-2在原发性肝癌生长、浸润及转移中的作用[J].胃肠病学和肝病学杂志, 2002, 11 (3) ∶225-228.
    [5]Kleiner D E, Stetler-Stevenson WG.Matrix metalloproteinasas andmetastasis[J].Cancer Chemother Pharmacol, 1999, 43 Suppl∶S42-51.
    [6]蒋扬富, 杨治华, 胡敬群, 等.血管内皮生长因子和基质金属蛋白酶-9在原发性肝癌中的表达及其临床意义[J].癌症, 2000, 19 (1) ∶17-19.
    [7]Bu W, Tang Z Y, Sun F X, et al.Effects of matrixmetalloproteinaseinhibitor BB-94 on liver cancer growth and metastasis in a patient-like orthotopic model LCID20[J].Hepatogastroenterology, 1998, 45 (22) ∶1056-1061.
    [8]Kuyvenhoven J P, van Hoek B, Blom E, et al.Assessment of theclinical significance of serum matrix metalloproteinases MMP-2 andMMP-9 in patients with various chronic liver diseases and hepato-cellular carcinoma[J].Thromb Haemost, 2003, 89 (4) ∶718-725.
    [9]McKenna G J, Chen Y, Smith R M, et al.Arole for matrix metallo-proteinases and tumor host interaction in hepatocellularcarcinomas[J].Am J Surg, 2002, 183 (5) ∶588-594.
    [10]蔡阳, 吴志全, 樊嘉等.膜型基质金属蛋白酶-1与肝细胞癌侵袭转移性的关系[J].中华肝脏病杂志, 2000, 8 (4) ∶236-238.
    [11]Martin D C, Fowlkes J L, Babic B, et al.Insulin-like growth fac-torⅡSignaling in neoplastic proliferation is blocked by transgenicexpression of the metalloproteinase inhibitor TIMP-1[J].J Cell Bi-ol, 1999, 146 (4) ∶881-892.
    [12]Bergers G, Coussens L M.Extrinsic regulators of epithelial tumorprogression:metalloproteinases[J].Curr Opin Genet Dev, 2000, 10 (1) ∶120-127.
    [13]Qi J H, EbrahemQ, Moore N, et al.Anovel function for tissue in-hibitor of metalloproteinases-3 (TIMP-3) :inhibition of angiogene-sis by blockage of VEGF binding to VEGF receptor-2[J].NatMed, 2003, 9 (4) ∶407-415.
    [14]Pang I H, Hellberg P E, Fleenor D L, et al.Expression of matrixmetalloproteinases and their inhibitors in human trabecular meshworkcells[J].Invest Ophthalmol Vis Sci, 2003, 44 (8) ∶3485-3493.
    [15]陈晓锋, 顾振纶, 梁中琴, 等.基质金属蛋白酶与肿瘤侵袭和转移研究进展[J].中国药理学通报, 2001, 17 (3) ∶253-256.
    [16]Fang J, Shing Y, Wiederschain D, et al.Matrix metalloproteinase-2 is required for the switch to the angiogenic phenotype in a tumormodel[J].Proc Natl Acad Sci USA, 2000, 97 (8) ∶3884-3889.
    [17]Kleiner DE, Stetler-Stevenson WG.Matrix metalloproteinasas andmetastasis[J].Cancer Chemother Pharmacol, 1999, 43 Suppl∶S42-51.
  • 加载中
计量
  • 文章访问数:  3379
  • HTML全文浏览量:  11
  • PDF下载量:  1419
  • 被引次数: 0
出版历程
  • 出版日期:  2008-02-20
  • 分享
  • 用微信扫码二维码

    分享至好友和朋友圈

目录

    /

    返回文章
    返回